Published • loading... • Updated
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
Summary by The Motley Fool
1 Articles
1 Articles
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
Key PointsKrensavage bought 241,245 Ultragenyx Pharmaceutical shares last quarter.The quarter-end position value increased by $4.75 million, reflecting both trading and share price changes.The trade represented a roughly 2% increase in reportable fund AUM.The quarter-end stake stood at 390,879 shares worth $8.19 million.10 stocks we like better than Ultragenyx Pharmaceutical › On May 14, 2026, Krensavage Asset Management disclosed it bought 241,…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
